Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-12

Clinical Trial Update: CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer

View source ↗

Summary

The CORRECT study evaluating minimal residual disease detection in colorectal cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Exact Sciences Corporation | Conditions: Colorectal Cancer | Status: ACTIVE_NOT_RECRUITING